We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
Report Puerto Rico - Other Medicaments for Therapeutic or Prophylactic Uses - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update May 1, 2024

Puerto Rico - Other Medicaments for Therapeutic or Prophylactic Uses - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
What's the difference?
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Puerto Rico: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2024

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Puerto Rico

The Puerto Rican market for other medicaments for therapeutic or prophylactic uses expanded significantly to $X in 2021, picking up by 5.9% against the previous year. Over the period under review, consumption continues to indicate a modest increase. Puerto Rico consumption peaked at $X in 2015; however, from 2016 to 2021, consumption remained at a lower figure.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Puerto Rico

In value terms, production of other medicaments for therapeutic or prophylactic uses expanded sharply to $X in 2021 estimated in export price. Overall, production continues to indicate a relatively flat trend pattern. The pace of growth was the most pronounced in 2014 with an increase of 67% against the previous year. As a result, production attained the peak level of $X. From 2015 to 2021, production of growth failed to regain momentum.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports by Country

India (X tons) and China (X tons) were the main exporters of other medicaments for therapeutic or prophylactic uses in 2021, resulting at near 16% and 15% of total exports, respectively. Canada (X tons) held the next position in the ranking, followed by the United States (X tons), France (X tons), Spain (X tons), Israel (X tons) and South Africa (X tons). All these countries together took approx. 39% share of total exports. The following exporters - Jordan (X tons), the UK (X tons), Italy (X tons), the Netherlands (X tons) and Belgium (X tons) - together made up 14% of total exports.

From 2012 to 2021, the biggest increases were recorded for Canada (with a CAGR of +10.6%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the United States ($X), Spain ($X) and Israel ($X) appeared to be the countries with the highest levels of exports in 2021, together comprising 30% of total exports. China, India, the Netherlands, France, Italy, Belgium, Jordan, Canada, the UK and South Africa lagged somewhat behind, together accounting for a further 31%.

In terms of the main exporting countries, China, with a CAGR of +7.3%, saw the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports by Country

In 2021, the United States (X tons), followed by France (X tons), Spain (X tons) and the UK (X tons) were the major importers of other medicaments for therapeutic or prophylactic uses, together achieving 27% of total imports. Mexico (X tons), India (X tons), Colombia (X tons), Brazil (X tons), Canada (X tons), Argentina (X tons), the Netherlands (X tons), China (X tons) and Nepal (X tons) followed a long way behind the leaders.

From 2012 to 2021, the biggest increases were recorded for China (with a CAGR of +19.2%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the United States ($X), the UK ($X) and Spain ($X) appeared to be the countries with the highest levels of imports in 2021, with a combined 24% share of total imports. These countries were followed by China, the Netherlands, Canada, Brazil, Mexico, India, France, Colombia, Argentina and Nepal, which together accounted for a further 19%.

Nepal, with a CAGR of +21.6%, recorded the highest rates of growth with regard to the value of imports, among the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

The country with the largest volume of consumption of other medicaments for therapeutic or prophylactic uses was China, accounting for 24% of total volume. Moreover, consumption of other medicaments for therapeutic or prophylactic uses in China exceeded the figures recorded by the second-largest consumer, the United States, twofold. The third position in this ranking was taken by India, with an 8.5% share.
China remains the largest other medicaments for therapeutic or prophylactic uses producing country worldwide, comprising approx. 25% of total volume. Moreover, production of other medicaments for therapeutic or prophylactic uses in China exceeded the figures recorded by the second-largest producer, the United States, twofold. The third position in this ranking was held by India, with a 10% share.
In value terms, the largest other medicaments for therapeutic or prophylactic uses importing markets into Puerto Rico were the United States, the UK and Spain, with a combined 24% share of total imports. China, the Netherlands, Canada, Brazil, Mexico, India, France, Colombia, Argentina and Nepal lagged somewhat behind, together accounting for a further 19%.
In value terms, the largest other medicaments for therapeutic or prophylactic uses supplying countries from Puerto Rico were the United States, Spain and Israel, with a combined 30% share of total exports. These countries were followed by China, India, the Netherlands, France, Italy, Belgium, Jordan, Canada, the UK and South Africa, which together accounted for a further 31%.

This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in Puerto Rico. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201320 - Other medicaments for therapeutic or prophylactic uses, of HS

Country coverage:

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Trade (exports and imports) in Puerto Rico
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS

  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO

  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. MARKET STRUCTURE
    3. TRADE BALANCE
    4. PER CAPITA CONSUMPTION
    5. MARKET FORECAST TO 2030

  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT

  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES

  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS

  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE

  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY

  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY

  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO

  11. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption In 2012-2023
    5. Imports, In Physical Terms, By Country, 2012–2023
    6. Imports, In Value Terms, By Country, 2012–2023
    7. Import Prices, By Country Of Origin, 2012–2023
    8. Exports, In Physical Terms, By Country, 2012–2023
    9. Exports, In Value Terms, By Country, 2012–2023
    10. Export Prices, By Country Of Destination, 2012–2023

  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
    4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
    5. Trade Balance, In Physical Terms, 2012-2023
    6. Trade Balance, In Value Terms, 2012-2023
    7. Per Capita Consumption, 2012-2023
    8. Market Volume Forecast to 2030
    9. Market Value Forecast to 2030
    10. Products: Market Size And Growth, By Type
    11. Products: Average Per Capita Consumption, By Type
    12. Products: Exports And Growth, By Type
    13. Products: Export Prices And Growth, By Type
    14. Production Volume And Growth
    15. Exports And Growth
    16. Export Prices And Growth
    17. Market Size And Growth
    18. Per Capita Consumption
    19. Imports And Growth
    20. Import Prices
    21. Production, In Physical Terms, 2012–2023
    22. Production, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, 2012–2023
    24. Imports, In Value Terms, 2012–2023
    25. Imports, In Physical Terms, By Country, 2023
    26. Imports, In Physical Terms, By Country, 2012–2023
    27. Imports, In Value Terms, By Country, 2012–2023
    28. Import Prices, By Country Of Origin, 2012–2023
    29. Exports, In Physical Terms, 2012–2023
    30. Exports, In Value Terms, 2012–2023
    31. Exports, In Physical Terms, By Country, 2023
    32. Exports, In Physical Terms, By Country, 2012–2023
    33. Exports, In Value Terms, By Country, 2012–2023
    34. Export Prices, By Country Of Destination, 2012–2023

Recommended reports

China - Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses - Market Analysis, Forecast, Size, Trends and Insights
$599
May 1, 2024
Eye 220

This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in China.

EU - Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses - Market Analysis, Forecast, Size, Trends and Insights
$599
May 1, 2024
Eye 217

This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in the EU.

World - Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses - Market Analysis, Forecast, Size, Trends and Insights
$599
May 1, 2024
Eye 306

This report provides an in-depth analysis of the global market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses.

Asia - Other Medicaments for Therapeutic or Prophylactic Uses - Market Analysis, Forecast, Size, Trends and Insights
$599
May 1, 2024
Eye 307

This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in Asia.

U.S. - Other Medicaments for Therapeutic or Prophylactic Uses - Market Analysis, Forecast, Size, Trends and Insights
$599
May 1, 2024
Eye 280

This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in the U.S..

Free Data: Medicaments; (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) - Puerto Rico
Table
Medicaments; (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) - Puerto Rico - Table
Dashboard
Medicaments; (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) - Puerto Rico - Dashboard
Report
Medicaments; (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) - Puerto Rico - Report